Surface Pharmaceuticals’ branded drug candidates are being developed to address targeted segments of the Dry Eye Disease (DED) market.
Location: United States, California, San Diego
Employees: 1-10
Total raised: $20M
Investors 2
| Date | Name | Website |
| - | Visionary ... | visionaryv... |
| - | Bluestem C... | bluestemca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.05.2018 | Series A | $20M | - |
Mentions in press and media 2
| Date | Title | Description |
| 03.09.2020 | Surface Pharmaceuticals Strengthens Leadership Team as Clinical Programs Advance in Eye Care | |
| 15.05.2018 | Surface Pharmaceuticals Raises $20M in Series A Financing | Surface Pharmaceuticals, Inc., an affiliated company of Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), entered into a stock purchase agreement with an affiliate of Flying L Partners to raise proceeds of up to approximately $20m in a private... |